Publications and Innovation

February 2016 - PAPR investigators presented the findings of the landmark PAPR study at the 2016 Society of Maternal-Fetal Medicine meeting. The conclusions of the study and resulting American Journal of Obstetrics & Gynecology was that a serum-based molecular predictor identifies asymptomatic pregnant women at risk of spontaneous preterm delivery, which may provide utility in identifying women at risk at an early stage of pregnancy to allow for clinical intervention.

March 2015 - Sera Prognostics, Inc. presented data demonstrating correlation between ELISA and MRM-MS at the Society of Reproductive Investigation 2015 Annual Meeting.

June 2014 – Sera Prognostics, Inc. presented the development and analytical performance of a highly multiplexed and targeted mass spectrometry-based assay for biomarker discovery and subsequent clinical diagnostic development.

March 2014 - Dr. Jay Boniface presented the strategy and methodology used for the discovery of proteins predictive of preterm birth risk at the 2014 Society for Gynecologic Investigation’s 61st Annual Scientific Meeting.

MAY 2011 - The innovative proteomic methods used by Drs. M. Sean Esplin and Steven W. Graves to identify novel biomarkers for the prediction of preterm birth were highlighted in the May 2011 issue of the American Journal of Obstetrics and Gynecology.

JUL 2009 - The online journal, Rapid Communications in Mass Spectometry, published a paper highlighting the use of an integrated serum proteomic approach as having high potential for discovery of new biomarkers.

Quote icon
“Through a systematic & rigorous approach to biomarker discovery we characterize the proteome of pregnancy. These significant discoveries pave the way toward a paradigm shift in obstetrical care in pregnancy and open the door to the identification of women at risk for aberrant conditions of pregnancy, such as preterm birth”.

Jay Boniface, PhD

Chief Scientific Officer

Jay Boniface, PhD, Chief Scientific Officer
Scroll to Top